Actively Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Led by Bristol-Myers Squibb · Updated on 2026-01-22
50
Participants Needed
8
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this transgene assay testing service is to evaluate tumor samples for transgene levels in patients who received a commercially available Bristol-Myers Squibb manufactured gene modified cellular therapy and have reported a qualifying second malignancy.
CONDITIONS
Official Title
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant has received a commercially available Bristol-Myers Squibb manufactured Gene Modified Cell Therapy and has been diagnosed with a qualifying second primary malignancy or a second primary malignancy qualified for testing by Bristol-Myers Squibb
- Participant has received a commercially available Bristol-Myers Squibb manufactured Gene Modified Cell Therapy in a clinical trial or investigational setting with no testing protocol in place for that trial or setting and has a qualifying second primary malignancy or one qualified for testing by Bristol-Myers Squibb
You will not qualify if you...
- Participant is actively participating in a clinical trial where information and sample collection is being conducted under that trial
- Participant has not received a Bristol-Myers Squibb manufactured Gene Modified Cell Therapy or has not been diagnosed with a qualifying second primary malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Local Institution - 0016
Portland, Oregon, United States, 97239-3098
Not Yet Recruiting
2
Ut Southwestern
Dallas, Texas, United States, 75235
Actively Recruiting
3
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States, 84112
Actively Recruiting
4
Local Institution - 0004
Madison, Wisconsin, United States, 53792
Withdrawn
5
Universitaetsklinikum Essen (AoR)
Essen, Germany, 45147
Actively Recruiting
6
Toyokawa City Hospital
Toyokawa, Aichi-ken, Japan, 442-8561
Actively Recruiting
7
Local Institution - 0003
Kumamoto, Kumamoto, Japan, 8608556
Withdrawn
8
Kantonsspital Aarau
Aarau, Switzerland, 5001
Actively Recruiting
Research Team
B
BMS Study Connect Contact Center www.BMSStudyConnect.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here